(EMAILWIRE.COM, January 31, 2010 ) Dallas, Tx - MannKind Corporation (NASDAQ:MNKD) is scheduled to report its fourth-quarter on Monday, February 01, 2010. The company is projected to narrow its loss to 40 cents a share compared to a loss of 82 cents in a year-ago period.

To subscribe these free daily stock market updates you can visit our website: http://www.SuperHotPennyStocks.com.

MannKind Corporation (MannKind) is a biopharmaceutical company focused on the discovery, development and commercialization of therapeutic products for diseases, such as diabetes and cancer. Its lead product candidate, AFRESA, is an ultra rapid-acting insulin that has completed Phase III clinical trials evaluating its safety and efficacy in the treatment of diabetes.

Crucell N.V. (ADR) (NASDAQ:CRXL) Analysts expect HK to post earnings of 15 cents per share on sales of $335.69 million. The oil and gas exploration and production company had a year earlier recorded a loss of $0.04 a share in earnings on revenues of $207.13 million.

Crucell N.V. (Crucell) is a biopharmaceutical company. The Company is focused on developing, producing and marketing products that combat infectious diseases. It develops products that address unmet medical needs, particularly in the field of infectious diseases.


ABOUT http://www.SuperHotPennyStocks.com


Super Hot Penny Stocks alerts its members on daily stock trading so that they can invest wisely. Thousands of investors receive our daily stock alerts and have made huge gains in the penny stock trading. You can also take advantage of the information provided, to be really successful in the stock market business. You can also feature your web link on our website by contacting us through email.

Contact Information:
Super Hot Penny Stocks
Robert
Tel: 214 556 6798
Email us


This is a press release. Press release distribution and press release services by EmailWire.Com: http://www.emailwire.com/us-press-release-distribution.php.